February 09, 2016

Accenture Achieves Lead Innovation Position in “Winner's Circle” for Business Process Outsourcing in the Utilities Industry in HfS Research Report

NEW YORK; Feb. 9, 2016 – Accenture (NYSE: ACN) has been positioned in the 'Winner's Circle' of HfS Research's inaugural Blueprint Report for Utilities Business Process Outsourcing (BPO). Accenture is ranked as one of the leaders in the report, which assessed seven service providers based on execution and innovation.
February 08, 2016

Accenture Named Leader in an IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment on Business Process Outsourcing

NEW YORK; Feb. 8, 2016 – Accenture is positioned as a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process outsourcing (BPO) across the life sciences research and development (R&D) industry. This is the second consecutive time Accenture has achieved this position. 
February 03, 2016

Accenture Completes Acquisition of Formicary, Strengthening Systems Integration and Technology Consulting Capabilities in Trading Systems Transformation

LONDON; Feb. 3, 2016 – Accenture (NYSE: ACN) has completed its acquisition of Formicary, a leading provider of systems integration and technology consulting services for trading platforms in the UK and North America.
February 02, 2016

Retailers’ Mobile Capabilities Lag Customer Demands, Accenture Research Finds

NEW YORK; Feb. 2, 2016 – Retailers are failing to meet consumer demand for increased convenience while shopping with mobile devices, according to new research from Accenture. 
February 02, 2016

Investment in On-Demand Healthcare to Reach $1 Billion in 2017, Accenture Finds

CHICAGO; Feb. 2, 2016 – New research from Accenture (NYSE: ACN) estimates that U.S. funding for on-demand healthcare companies – those providing location-based offerings with near-real-time and 24/7 services – will quadruple from over $200 million in 2014 to $1 billion by the end of 2017.
February 02, 2016

More than Half of Insurers Consider Setting Up Aggregator Sites to Sell Their Own and Other Insurers’ Products, Accenture Study Finds

NEW YORK and LONDON; Feb. 2, 2016 – More than half of the 400 insurers surveyed globally in a recent Accenture (NYSE: ACN) study are considering setting up their own aggregator sites – online sites that allow insurers to sell their own and other insurers’ products. 
February 01, 2016

Accenture Positioned the Furthest and Highest within “Leaders” Quadrant in Gartner’s 2015 Magic Quadrant for Oracle Application Management Services, Worldwide

NEW YORK; Feb. 1, 2016 – Accenture (NYSE: ACN) is positioned furthest and highest in the “Leaders” quadrant within the Gartner Magic Quadrant for Oracle Application Management Services, Worldwide, for both ability to execute and completeness of vision. 
February 01, 2016

Accenture Develops Virtual Reality Proof of Concept Bringing Data to Life During RBS 6 Nations Rugby Championship

LONDON; Feb. 1, 2016 – Accenture (NYSE: ACN), the Official Technology Partner of the RBS 6 Nations Rugby Championship, has developed a virtual reality experience to demonstrate the potential of the technology for rugby fans, and potential applications outside of game-playing.
January 28, 2016

Accenture Helps FirstEnergy Identify More Than $450 Million in Cost Savings Over Three Years

AKRON, OHIO; Jan. 28, 2016 – Accenture (NYSE: ACN) has helped FirstEnergy  (NYSE: FE), a leading U.S. diversified energy company, develop its Cash Flow Improvement Program (CFIP) that is expected to help deliver $453 million in cost savings over the next three years. 
January 28, 2016

Boston Scientific and Accenture Develop Data-Driven Digital Health Solution to Help Improve Patient Outcomes and Reduce Cost of Treating Chronic Cardiovascular Conditions

MARLBOROUGH, Mass. and NEW YORK; Jan. 28, 2016 – Boston Scientific Corporation (NYSE: BSX) and Accenture (NYSE: ACN) have developed a cloud-based, data-driven digital health solution for hospitals that is designed to help improve patient outcomes and reduce costs to treat patients with chronic cardiovascular diseases.